AINov 18, 2026

Boltz raises $110.0M (Nov 2026)

$110.0M
$110 million

Find the investors funding AI rounds

326,000+ VC, angel and family-office profiles — direct emails, check sizes and stage filters.

Find your investors →
Headline

Boltz raises $110 million as weekly use of its AI drug design models rises about 50-fold - MLQ.ai

About

Boltz is an AI company focused on drug design. The company has raised $110 million, indicating significant investor confidence in its AI-driven approach to pharmaceutical development. Weekly usage of its AI drug design models has seen a substantial increase, suggesting strong market adoption and validation of its technology.

Article summary

Boltz raises $110 million as weekly use of its AI drug design models rises about 50-fold  MLQ.ai

Investors
Related rounds
Nov 19, 2026Stryx AI$8.3MSeed—
Nov 18, 2026Perry AI$2.2MSeed—
Nov 18, 2026Caper AI$13.0M——
Nov 18, 2026Zhiye Technology$4.5MSeries A—

Find the investors behind rounds like this one

You just read who funded Boltz. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.

Free account: 15 investor contact unlocks a month, no card required.

About the investors